The Virginia Osteopathic Medical Association (VOMA) respectfully opposes the proposed removal of the requirement that the supervising or collaborating physician’s or podiatrist’s name appear on prescriptions issued by physician assistants for Schedule II–V medications.

This requirement serves as an important safeguard that reinforces the physician-led, team-based model of care and ensures transparency in prescribing practices—particularly for controlled substances. Removing the physician’s name from these prescriptions risks blurring the distinction between physician and non-physician prescribing, which may lead to confusion for patients, pharmacists, and regulators.

Moreover, physicians remain ultimately responsible and legally liable for the care delivered under their supervision. Eliminating this requirement creates a misalignment between accountability and visibility, whereby physicians retain liability without clear identification on the prescription itself.

At a time when the Commonwealth continues to address concerns related to controlled substance prescribing and patient safety, maintaining clear lines of authority and accountability is essential. Preserving the inclusion of the supervising physician’s name supports patient safety, reinforces appropriate oversight, and upholds the integrity of the physician-led care model.

For these reasons, VOMA strongly urges that this requirement remain in place.